Dishman May Sell API Facility in China

Dishman Pharmaceuticals & Chemicals (Ahmedabad, India), tells CW that it may sell its large-scale facility in the Shanghai Chemical Industrial Park at Caojing, China, which produces pharma intermediates, active pharmaceutical ingredients (APIs), and highly potent APIs. “We are still evaluating our options for the Shanghai plant, and this includes discussions with interested parties,” says Christian Dowdeswell, commercial director at Dishman. The company declined to comment on the reasons for the possible sale, and did not disclose the names of the...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers